MAT Clinics in Missouri: Methadone, Suboxone & Vivitrol Treatment

Get Help Finding a Clinic in Missouri

Need help exploring Missouri treatment options?

Talk through methadone, buprenorphine, insurance and travel questions. You can also send a request using the form below.

Call 1-(347) 591-7540

Please enable JavaScript in your browser to complete this form.

Your Information - Step 1 of 2

First Name *

Last Name *

Phone Number *

Email Address *

Next

What treatment option are you interested in? *Methadone TreatmentBuprenorphine / Suboxone TreatmentNaltrexone / Vivitrol TreatmentCounseling OnlyNot Sure Yet

Who is this for? *MyselfA Loved One

Do you have insurance? *YesNoNot Sure

What state are you located in? *AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming

I agree to be contacted by phone, text, or email about treatment options. I understand this is not a guarantee of treatment placement or insurance coverage. *

• I agree

are utm_content option

Find My Treatment Options

For an overdose or immediate danger, call 911. For a mental health crisis, call or text 988. SAMHSA National Helpline: 1-800-662-4357.

MATClinicGuide.com is an education and navigation service, not a clinic. Calls reach our navigation line and may be answered by or routed to participating treatment providers or navigation partners.

MAT Treatment Options in Missouri by Medication

Methadone clinics in Missouri

Missouri has 14 Medicare-enrolled OTP locations in 11 cities, with three in Kansas City and two in Springfield. Methadone for opioid use disorder is dispensed through certified opioid treatment programs, not ordinary retail pharmacies. At the start, people may attend often while the care team establishes a safe schedule. Ask about treatment hours, intake and potential take-home doses; the appropriate plan is individual. Read the methadone treatment guide and how OTPs work.

Buprenorphine and Suboxone doctors in Missouri

Suboxone and other buprenorphine products may be prescribed in medical offices, including primary care and addiction medicine, and by eligible telehealth clinicians subject to current rules. For Missouri residents outside the 11 CMS-listed OTP cities, office-based care may reduce the need to travel for medication. The former federal X-waiver requirement ended in 2023, but clinicians still must meet prescribing requirements. Search local buprenorphine providers in Missouri and read the buprenorphine and Suboxone guide.

Long-acting injectable buprenorphine: Sublocade and Brixadi

Sublocade and Brixadi are long-acting buprenorphine injections administered by qualified health professionals. They can be useful when a person and clinician prefer an injection schedule rather than daily self-administered medication. In Missouri, ask an addiction medicine practice or treatment program whether these injections are available and what steps are needed before the first dose. The best choice depends on medical history, current opioid use, treatment goals and coverage. Learn more about Sublocade treatment and discuss Brixadi with a clinician.

Naltrexone and Vivitrol in Missouri

Extended-release naltrexone (Vivitrol) is a non-opioid medication option for opioid use disorder, but it generally requires an opioid-free period before treatment to avoid precipitated withdrawal. Missouri patients can ask their clinician whether an injection program is available through outpatient addiction care. Because beginning naltrexone involves different preparation than methadone or buprenorphine, medical assessment is important. Explore the naltrexone and Vivitrol guide and compare options with a qualified professional.

Paying for MAT in Missouri

MO HealthNet (Missouri Medicaid)

MO HealthNet is Missouri’s Medicaid program. The state implemented Medicaid expansion on October 1, 2021 after voters adopted the expansion in August 2020 (KFF, October 2026). Federal Medicaid law requires coverage of medication treatment for opioid use disorder, including methadone, buprenorphine and naltrexone. Specific pharmacy arrangements, authorization rules and network providers depend on the medication and coverage.

Use the official MO HealthNet healthcare website to review enrollment and eligibility. When calling a Missouri clinic, give your current coverage information and ask about medication, visit and lab charges.

Medicare

Medicare Part B has an OTP benefit for eligible treatment services at participating programs. Prescription coverage for medications dispensed outside an OTP depends on the applicable Medicare benefit and plan rules. Ask the Missouri location and your plan how methadone services and take-home prescriptions are handled.

Private insurance

Private insurance may cover medication treatment for opioid use disorder, but plan networks, cost sharing and medication-specific requirements differ. Parity protections do not mean every clinician or product is covered at every location. Ask whether your chosen Missouri practice is in network and whether prior authorization applies.

Without insurance

Missouri DMH Division of Behavioral Health funds substance use services. People without coverage can contact the Division at 1-800-575-7480 to explore available programs and eligibility. You can also ask a local clinic whether it offers payment help or connects patients to other community services. See insurance coverage, insurance verification and MAT costs and insurance.

Opioid Overdose in Missouri: Why Access Matters

Missouri recorded 1,461 drug overdose deaths in 2024, down from 2,192 in 2022, according to CDC NCHS data presented by KFF. The state’s age-adjusted all-drug overdose death rate dropped from 36.9 per 100,000 in 2022 to 23.7 in 2024. These figures cover all drugs, not only opioids.

In 2024 the national all-drug rate was 23.1 per 100,000, compared with Missouri’s 23.7; the national opioid rate was 16.0, compared with Missouri’s 15.3 (CDC NCHS via KFF). A lower statewide rate does not remove the need for accessible medication treatment and overdose-response support. Learn about overdose response and naloxone.

Missouri Resources and Helplines

Naloxone and Good Samaritan protections

Missouri pharmacists may provide naloxone to family members, friends and community members, including minors when the pharmacist considers it reasonable. Medicaid and private insurance may make it free or low cost; over-the-counter purchase may cost about $45 or more. Ask the pharmacy about stock and price.

Missouri’s Good Samaritan protections may shield the caller seeking emergency help and the person experiencing an overdose from specified minor drug and alcohol violations. They do not extend to all crimes, such as distribution or manufacturing, active warrants or drug-induced murder. Call 911 for a suspected overdose.

How to Choose a MAT Clinic in Missouri

Choosing a Missouri provider starts with confirming the medication offered, whether the clinic accepts new patients and how appointments fit work or travel. Use these questions when comparing methadone OTPs in Kansas City, Springfield or another city with office-based buprenorphine care.

Questions to ask before you call

• For methadone OTPs: Is the clinic accepting new patients?
• What are the intake and dosing hours?
• How are take-home doses assessed?
• Can the program coordinate guest dosing or transfers within Missouri?
• Does it accept my MO HealthNet, Medicare or private insurance?
• For buprenorphine: Does the clinician offer Suboxone or another formulation?
• Can the first visit or follow-ups happen by telehealth?
• Does the practice provide injectable buprenorphine or Vivitrol?
• What will visits, medication and pharmacy charges cost?
• How does the team handle medication questions between visits?

What happens at the first visit?

1. Discuss opioid use, current symptoms and treatment goals.
2. Review your health history, medications and insurance or payment choices.
3. Discuss options, expected monitoring and a safe start plan with the clinician.
4. Arrange follow-up care, naloxone and additional support when helpful.

For a broader primer, see OUD medications, MAT versus MOUD, treatment duration, counseling and medication and supporting someone you love.

Sources, Methodology and Editorial Standards

1. CMS Medicare Opioid Treatment Program Providers (September 8, 2026)
2. Missouri Department of Mental Health, contact information
3. Missouri statewide naloxone standing order (June 3, 2026)
4. KSMU, June 16, 2026: Missouri naloxone standing order
5. Time2Act Missouri: Good Samaritan protections
6. KFF Medicaid expansion status (October 2026)
7. KFF/CDC NCHS overdose death rates (2019–2024)

The Missouri clinic directory was compiled from the CMS Medicare Opioid Treatment Program Providers file dated September 8, 2026, grouped by location and compared with the state resource and policy references above. Medicare enrollment is a directory criterion, not a complete count of every operating clinic. Content is educational; MATClinicGuide.com does not own, operate or clinically supervise the listed programs.

Medical disclaimer: This page does not diagnose, prescribe or recommend a specific treatment for an individual. Discuss medication, withdrawal, pregnancy and other clinical concerns with a licensed professional.

Referral disclosure: MATClinicGuide.com provides education and treatment navigation rather than clinical care. Calling our number connects you with MATClinicGuide’s navigation line, not directly with any clinic shown in the directory. Calls may be answered by or routed to participating treatment providers or navigation partners. Confirm appointment, coverage and clinical information directly with the provider. For an emergency, call 911; for crisis support, call or text 988.

Read our editorial policy, medical disclaimer and advertising and referral disclosure.